NovaaOne Capital Private Ltd has submitted to the Exchange a copy of Detailed public statement in terms of Regulations 3(1) and 4 Read with Regulations 13(4), 14 (3) and 15(2) and other applicable regulations of the securities and Exchange Board of India (SAST) Regulations, 2011 , as amended, to the eligible shareholders ( as defined below) of the company.
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals Limited has announced a mandatory open offer to acquire up to 4.17 crore equity shares (26% of the expanded share capital) of JB Chemicals & Pharmaceuticals from eligible public shareholders at INR 1,639.18 per share, aggregating to approximately INR 6,843 crore assuming full acceptance. The open offer is triggered by an underlying transaction where Torrent is acquiring about 46.39% stake from the promoter seller (Taurer Investment Holdings) and other sellers through Share Purchase Agreements (SPA1 and SPA2). The public announcement was made on June 29, 2025, and this Detailed Public Statement was published on July 4, 2025 across national and regional newspapers. The offer is managed by NovaaOne Capital Private Limited, with Axis Capital as the buying broker. The tendering period is expected to open around August 19, 2025 and close on September 3, 2025.
Eligible shareholders of JB Chemicals can tender their shares at INR 1,639.18 per share in cash during the tendering period, with the offer price reflecting a premium over recent trading levels. The stock is likely to trade near the offer price during the open offer window, and shareholders should weigh the guaranteed exit price against potential long-term upside.